Table 1.
Characteristics | All (n = 600) | Premenopausal group (n = 304) | Postmenopausal group (n = 296) | T/χ2 | p |
---|---|---|---|---|---|
Age | 51.43 ± 10.68 | 43.72 ± 6.68 | 59.360 ± 7.868 | -26.220 | 0.000 |
Overweight/obesity | 248 (41.33) | 107 (35.20) | 141 (47.64) | 9.568 | 0.002 |
Type 2 diabetes | 51 (8.50) | 13 (4.28) | 38 (12.84) | 14.134 | 0.000 |
Hypertension | 227 (37.83) | 80 (26.32) | 147 (49.66) | 34.755 | 0.000 |
Hyperlipidemia | 116 (19.33) | 50 (16.45) | 66 (22.30) | 3.291 | 0.070 |
LP (a) | 0.594 | 0.441 | |||
≤ 500 mg/L | 535 (89.17) | 274 (90.13) | 261 (88.18) | ||
> 500 mg/L | 65 (10.83) | 30 (9.86) | 35 (11.82) | ||
Hyperuricemia | 68 (11.33) | 27 (8.88) | 41 (13.85) | 3.686 | 0.055 |
Axillary lymph node metastasis | 262 (48.25) | 129 (46.07) | 133 (50.57) | 1.099 | 0.294 |
BMI Body Mass Index, LP (a) Lipoprotein (a)